India:
India Kept Out Of The Priority List By The US Trade Representative (USTR)
15 July 2014
S&A Law Offices
To print this article, all you need is to be registered or login on Mondaq.com.
In one of the recent decision by the US trade representative,
Indian IP should be kept away from the US IPR priority list. This
decision took place after the US industry had raised the matter of
India's rejection of patents for Bristol-Myers Squibb's
Sprycel and Novartis AG's Glivec. Intellectual Property Office,
India has always maintained that its IPR regime is fully compliant
with WTO norms and it would drag the US to the global trade body if
any adverse unilateral step is taken against the country in
IPR-related matters.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from India
What Is Fair Use Of Copyright Doctrine?
Photon legal
Have you ever used a copyrighted work without permission, and wondered whether it was legal or not? You might have heard of the term "fair use," but what exactly does it mean?
An Overview Of Evergreening Patents
Photon legal
Do you know that there's a way to evergreen your patents? Evergreen, as the name suggests, is something that will last for a lifetime. Therefore, Evergreening of patents is a process...
Trademarks Comparative Guide
Obhan & Associates
Trademarks Comparative Guide for the jurisdiction of India, check out our comparative guides section to compare across multiple countries